X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (45) 45
oncology (37) 37
cancer (30) 30
index medicus (26) 26
chemotherapy (25) 25
radiotherapy (23) 23
female (21) 21
male (21) 21
middle aged (21) 21
aged (19) 19
care and treatment (17) 17
combined modality therapy (17) 17
head and neck cancer (17) 17
squamous-cell carcinoma (15) 15
adult (14) 14
antineoplastic combined chemotherapy protocols - therapeutic use (14) 14
cisplatin (12) 12
clinical trials (12) 12
head (12) 12
head and neck neoplasms - drug therapy (12) 12
carcinoma (11) 11
hematology, oncology and palliative medicine (11) 11
neoplasm staging (11) 11
radiology, nuclear medicine & medical imaging (11) 11
article (10) 10
squamous cell carcinoma (10) 10
antineoplastic agents - therapeutic use (9) 9
carcinoma, squamous cell - drug therapy (9) 9
carcinoma, squamous cell - radiotherapy (9) 9
cisplatin - administration & dosage (9) 9
esophageal cancer (9) 9
head and neck neoplasms - mortality (9) 9
head and neck neoplasms - pathology (9) 9
head and neck neoplasms - therapy (9) 9
medicine, general & internal (9) 9
neck (9) 9
radiation-therapy (9) 9
head and neck neoplasms - radiotherapy (8) 8
health aspects (8) 8
locally advanced head (8) 8
radiation (8) 8
radiology (8) 8
radiology and nuclear medicine (8) 8
research (8) 8
survival analysis (8) 8
treatment outcome (8) 8
aged, 80 and over (7) 7
carcinoma, squamous cell - mortality (7) 7
carcinoma, squamous cell - surgery (7) 7
fluorouracil - administration & dosage (7) 7
patient outcomes (7) 7
patients (7) 7
surgery (7) 7
adenocarcinoma (6) 6
analysis (6) 6
antineoplastic combined chemotherapy protocols - adverse effects (6) 6
cisplatin - therapeutic use (6) 6
disease-free survival (6) 6
drug therapy (6) 6
esophageal neoplasms - drug therapy (6) 6
growth-factor receptor (6) 6
human-papillomavirus (6) 6
neck-cancer (6) 6
radiotherapy dosage (6) 6
randomized-trial (6) 6
survival rate (6) 6
abridged index medicus (5) 5
antineoplastic agents - adverse effects (5) 5
carcinoma, squamous cell - pathology (5) 5
carcinomas (5) 5
chemoradiotherapy (5) 5
docetaxel (5) 5
expression (5) 5
fluorouracil (5) 5
medicine & public health (5) 5
neoplasms (5) 5
oropharyngeal cancer (5) 5
quality-of-life (5) 5
randomized controlled trials as topic (5) 5
retrospective studies (5) 5
toxicity (5) 5
adenocarcinoma - drug therapy (4) 4
carcinoma, squamous cell - genetics (4) 4
cetuximab (4) 4
chemoradiation (4) 4
cisplatin - adverse effects (4) 4
diagnosis (4) 4
diseases (4) 4
dosage and administration (4) 4
drug administration schedule (4) 4
esophageal neoplasms - radiotherapy (4) 4
esophageal neoplasms - therapy (4) 4
esophagus (4) 4
genetic aspects (4) 4
hazards (4) 4
head and neck neoplasms - epidemiology (4) 4
head and neck neoplasms - surgery (4) 4
head and neck neoplasms - virology (4) 4
laryngeal neoplasms - drug therapy (4) 4
laryngeal neoplasms - radiotherapy (4) 4
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet Oncology, The, ISSN 1470-2045, 2013, Volume 14, Issue 8, pp. 697 - 710
Summary Background Previous trials have shown that anti-EGFR monoclonal antibodies can improve clinical outcomes of patients with recurrent or metastatic... 
Hematology, Oncology and Palliative Medicine | SURVIVAL | P16 | ONCOLOGY | COLORECTAL-CANCER | OROPHARYNGEAL CANCER | HUMAN-PAPILLOMAVIRUS | P16(INK4A) | SUBSET | III TRIAL | COOPERATIVE-ONCOLOGY-GROUP | PLUS FLUOROURACIL | Immunohistochemistry | South America | Head and Neck Neoplasms - virology | Prospective Studies | Carcinoma, Squamous Cell - virology | Humans | Middle Aged | Neoplasm Recurrence, Local - virology | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Neoplasm Recurrence, Local - drug therapy | Male | North America | Cisplatin - administration & dosage | Neoplasm Recurrence, Local - pathology | Head and Neck Neoplasms - chemistry | Neoplasm Metastasis | Carcinoma, Squamous Cell - mortality | Cyclin-Dependent Kinase Inhibitor p16 - analysis | Fluorouracil - administration & dosage | Time Factors | Female | Retrospective Studies | Biomarkers, Tumor - analysis | Europe | Head and Neck Neoplasms - drug therapy | Kaplan-Meier Estimate | Proportional Hazards Models | Carcinoma, Squamous Cell - chemistry | Treatment Outcome | Papillomaviridae - isolation & purification | Neoplasm Recurrence, Local - chemistry | Head and Neck Neoplasms - pathology | Disease-Free Survival | Carcinoma, Squamous Cell - drug therapy | Antibodies, Monoclonal - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Asia | Biopsy | Carcinoma, Squamous Cell - secondary | Aged | Head and Neck Neoplasms - mortality | Care and treatment | Relapse | Carcinoma | Monoclonal antibodies | Product development | Metastasis | Cisplatin | Cancer | Diseases | Index Medicus
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2012, Volume 84, Issue 5, pp. 1198 - 1205
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2016, Volume 94, Issue 4, pp. 738 - 746
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2012, Volume 84, Issue 4, pp. 983 - 989
Purpose Concurrent chemoradiation therapy (CCRT) for squamous cell carcinoma of the head and neck (SCCHN) increases local tumor control but at the expense of... 
Radiology | Hematology, Oncology and Palliative Medicine | DYSPHAGIA | PHASE-II TRIAL | MULTICENTER | ONCOLOGY | CONCURRENT CHEMOTHERAPY | INTENSITY-MODULATED RADIOTHERAPY | RANDOMIZED-TRIAL | RADIATION | CARCINOMA | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | SWALLOWING DYSFUNCTION | Organs at Risk - radiation effects | Chemoradiotherapy - adverse effects | Age Factors | Carcinoma, Squamous Cell - pathology | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Carcinoma, Squamous Cell - radiotherapy | Patient Selection | Squamous Cell Carcinoma of Head and Neck | Hypopharynx - radiation effects | Female | Retrospective Studies | Radiotherapy Dosage | Chemoradiotherapy - methods | Head and Neck Neoplasms - drug therapy | Survivors | Head and Neck Neoplasms - pathology | Radiation Injuries - etiology | Head and Neck Neoplasms - radiotherapy | Regression Analysis | Carcinoma, Squamous Cell - drug therapy | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Aged | Neoplasm Staging | Dose-Response Relationship, Radiation | Medical colleges | Squamous cell carcinoma | Radiotherapy | Nuclear radiation | Index Medicus | Age | HEAD | PATIENTS | DEATH | RADIATION DOSES | TOXICITY | PNEUMONIA | MULTIVARIATE ANALYSIS | CARCINOMAS | RADIOLOGY AND NUCLEAR MEDICINE | FEEDING | NECK | RADIOTHERAPY | DOSIMETRY
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2012, Volume 83, Issue 1, pp. 235 - 242
Purpose To define the roles of radiotherapy and chemotherapy on the risk of Grade 3+ mucositis during intensity-modulated radiation therapy (IMRT) for... 
Radiology | Hematology, Oncology and Palliative Medicine | Intensity-modulated radiation therapy | Chemotherapy | Mucositis | HEAD | MUCOSAL REACTIONS | IMRT | PHASE-III | NECK-CANCER | ALTERED FRACTIONATION | ONCOLOGY | CONFORMAL RADIOTHERAPY | ORAL MUCOSITIS | QUALITY-OF-LIFE | CARCINOMA | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Confidence Intervals | Radiotherapy Planning, Computer-Assisted - methods | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Thiazoles - administration & dosage | Oropharyngeal Neoplasms - pathology | Radiotherapy, Intensity-Modulated - adverse effects | Cisplatin - administration & dosage | Mouth Mucosa - drug effects | Antibodies, Monoclonal, Humanized | Mouth Mucosa - radiation effects | Fluorouracil - administration & dosage | Fluorouracil - adverse effects | Stomatitis - pathology | Aged, 80 and over | Adult | Female | Cetuximab | Mouth Mucosa - pathology | Odds Ratio | Taxoids - adverse effects | Radiotherapy Dosage | Dasatinib | Oropharyngeal Neoplasms - drug therapy | Pyrimidines - administration & dosage | Induction Chemotherapy - methods | Oropharyngeal Neoplasms - radiotherapy | Tumor Burden | Stomatitis - etiology | Induction Chemotherapy - adverse effects | Radiography | Taxoids - administration & dosage | Antibodies, Monoclonal - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Organs at Risk - diagnostic imaging | Cisplatin - adverse effects | Aged | Care and treatment | Nuclear radiation | Radiation | Radiotherapy | Throat cancer | Health aspects | Cancer | Index Medicus | Acute toxicity | MULTIVARIATE ANALYSIS | PATIENTS | NEOPLASMS | RADIOLOGY AND NUCLEAR MEDICINE | MEDICAL PERSONNEL | RADIATION DOSES | TOXICITY | NECK | RADIOTHERAPY | CHEMOTHERAPY | HAZARDS | MUCOUS MEMBRANES
Journal Article
1984, Contemporary issues in clinical oncology, ISBN 9780443082740, Volume 2, xi, 307
Book
Journal of the National Cancer Institute, ISSN 0027-8874, 2/2008, Volume 100, Issue 4, pp. 261 - 269
Journal Article
Journal Article
Journal Article